These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6376194)
21. Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection. Barlow JJ; Lele SB; Emrich LJ Am J Obstet Gynecol; 1985 Jun; 152(3):310-4. PubMed ID: 2988337 [TBL] [Abstract][Full Text] [Related]
22. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169 [TBL] [Abstract][Full Text] [Related]
23. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012 [TBL] [Abstract][Full Text] [Related]
24. Pelvic irradiation for stage II ovarian carcinoma. Terada KY; Morley GW; Roberts JA Gynecol Oncol; 1988 Jan; 29(1):26-31. PubMed ID: 3338660 [TBL] [Abstract][Full Text] [Related]
25. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Meier W; du Bois A; Reuss A; Kuhn W; Olbricht S; Gropp M; Richter B; Lück HJ; Kimmig R; Pfisterer J Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314 [TBL] [Abstract][Full Text] [Related]
26. The Intergroup Rhabdomyosarcoma Study-I. A final report. Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486 [TBL] [Abstract][Full Text] [Related]
27. Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer. Alagaratnam TT; Wong J Aust N Z J Surg; 1986 Jan; 56(1):39-41. PubMed ID: 3090987 [TBL] [Abstract][Full Text] [Related]
28. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374 [TBL] [Abstract][Full Text] [Related]
29. Small cell carcinoma of the lung: results of combination chemotherapy and radiation therapy (COF vs. COFP randomized analyzed). Zhang ZY; Wang SZ; Zhang XF Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2139-43. PubMed ID: 6092309 [TBL] [Abstract][Full Text] [Related]
30. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501 [TBL] [Abstract][Full Text] [Related]
31. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial. Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814 [TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : four-year outcomes. Rochet N; Lindel K; Katayama S; Schubert K; Herfarth K; Schneeweiss A; Sohn C; Harms W; Debus J Strahlenther Onkol; 2015 Jul; 191(7):582-9. PubMed ID: 25786589 [TBL] [Abstract][Full Text] [Related]
35. Advances in the management of epithelial ovarian cancer. Berkenblit A; Cannistra SA J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567 [TBL] [Abstract][Full Text] [Related]
36. [Results of the 1st Austrian ovarian cancer study: prospective randomized comparison of a new sequential chemotherapy with 2 standard regimens in 150 stage III and IV patients]. Sevelda P; Salzer H; Gitsch E; Karrer K Onkologie; 1985 Dec; 8(6):388-91. PubMed ID: 3912695 [TBL] [Abstract][Full Text] [Related]
37. Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. Macbeth FR; Macdonald H; Williams CJ Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):353-8. PubMed ID: 3403316 [TBL] [Abstract][Full Text] [Related]
38. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795 [TBL] [Abstract][Full Text] [Related]
39. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503 [TBL] [Abstract][Full Text] [Related]